GEXVal
Latest round
- Series C
Last raised
- Jun 2024
Total raised
- $14M
Investors
- 13
About GEXVal
Based in Japan, GEXVal Inc., founded in 2018, is located in Fujisawa-shi, Japan. The company specializes in pharmaceuticals aimed at improving treatment access for patients. GEXVal has successfully completed 5 deals, with the most recent deal occurring on January 16, 2025.GEXVal specializes in the development and delivery of innovative pharmaceutical products aimed at enhancing treatment options for patients. The company's core offerings include a range of medicines designed to address various health conditions, focusing on affordability and accessibility to ensure that patients have timely access to essential treatments. GEXVal prioritizes patient needs and emphasizes research and development in its product pipeline, which reflects its commitment to delivering effective therapeutic solutions.GEXVal generates revenue through strategic partnerships and direct sales of its pharmaceutical products to healthcare providers and institutions. The company's transaction structure is primarily B2B, supplying products to hospitals and clinics that then provide them to end-users, such as patients in need of treatment. GEXVal’s revenue model includes one-time purchases of individual products or ongoing contracts with healthcare facilities to supply a range of medicines consistently. The firm's flagship products have garnered attention within the industry and are integral to its revenue stream, as they address significant treatment gaps while being priced competitively in the market.In January 2025, GEXVal Inc. The company plans to utilize these funds for the research and development of Phase II clinical trials of their product "GXV-001". Additionally, GEXVal is strategizing for expansion into new geographical markets to enhance their reach and effectiveness by targeting regions across Asia, Europe, and North America. The introduction of new products in the pipeline is expected to further solidify their market presence.
Who invested in GEXVal
13 investors across 4 rounds
See all investors in GEXVal
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GEXVal
Who invested in GEXVal?
GEXVal has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GEXVal raised?
GEXVal has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did GEXVal last raise money?
GEXVal's most recent round on record is a Series C, in Jun 2024.
What does GEXVal do?
GEXVal is a pharmaceuticals company.
Where is GEXVal headquartered?
GEXVal is headquartered in Fujisawa-shi, Japan.
Which VCs invest in companies like GEXVal?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at GEXVal's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like GEXVal? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.